Lawrence Kenyon, CFO & Sec at Insys Therapeutics, holds 0.00 shares in Insys Therapeutics (Ticker: INSYQ), holds 5.95K shares in Outlook Therapeutics (Ticker: OTLK), holds 93.48K shares in Oncobiologics Inc (Ticker: ONSIU). Most recently, Lawrence Kenyon ― shares of Insys Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Lawrence Kenyon?
The percentage of profitable transactions made by Lawrence Kenyon is 67%.
What is the average return per transaction made by Lawrence Kenyon?
The average return per transaction made by Lawrence Kenyon is -22.20%.
What stocks does Lawrence Kenyon hold?
Lawrence Kenyon holds: INSYQ, ONSIU, OTLK, PRX stocks.
What was Lawrence Kenyon’s latest transaction?
Lawrence Kenyon latest transaction was an Uninformative Buy of ―.
What was Lawrence Kenyon's most profitable transaction?
Lawrence Kenyon’s most profitable transaction was an Informative Buy of OTLK stock on September 30, 2024. The return on the trade was 18.30%.
What is Lawrence Kenyon's role in Insys Therapeutics?
Lawrence Kenyon's role in Insys Therapeutics is CFO & Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.